Biotech behind promising Covid vaccine pivots to veterinary medicine, spins off two divisions


Akston Biosciences Corporation is set to focus on drugs for animals, including insulin for dogs and cats, a cancer drug for dogs and a chronic pain drug for dogs.

Previous New York real estate firm buys Northwest Side apartment complex
Next Catholic Health CEO transition in works for months